Prevalence of Drug-resistant Klebsiella pneumoniae in Iran: A Review Article
- PMID: 29845018
- PMCID: PMC5971167
Prevalence of Drug-resistant Klebsiella pneumoniae in Iran: A Review Article
Abstract
Background: The infections caused by drug resistant strains of Klebsiella pneumoniae are becoming an important health problem worldwide. There are several reports on antimicrobial resistant status of K. pneumoniae in Iran. However, a comprehensive analysis on drug-resistant K. pneumoniae from different parts of Iran has not yet been performed.
Methods: The searches were done according to several English and Persian databases including PubMed, Scopus, Iranmedex, and SID to identify studies addressing antibiotic resistant K. pneumoniae in Iran from Jan 1998 to Nov 2014. Comprehensive Meta-Analysis (V2.2, Biostat) software was used to analyze the data.
Results: The incidence rate of imipenem and ceftazidime resistance in K. pneumoniae isolates was 3.2% (95% confidence interval [CI], 1.5-6.5) and 55.7% (95% CI, 46.9-64.1), respectively. The highest rate of resistance in isolates of K. pneumoniae was seen against ampicillin (82.2%), aztreonam (55.4%) and nitrofurantoin (54.5%).
Conclusion: There is a relatively high prevalence of drug resistant K. pneumoniae isolates in Iran. Thus, a high degree of awareness among physicians and microbiologists, active infection control committee, appropriate antimicrobial therapy, improvement of hygiene condition and monitoring of drug resistant isolates are urgently needed in order to better control the emergence and spread of drug-resistant K. pneumoniae isolates in hospital settings.
Keywords: Drug resistance; Iran; Klebsiella pneumoniae.
Conflict of interest statement
Conflict of Interests The authors declare that there is no conflict of interests.
Figures






References
-
- Heidary M, Goudarzi H, Hashemi A, et al. (2016). The prevalence of genes that encode quinolone resistance in Klebsiella pneumoniae strains isolated from hospitalized patients during 2013–2014. Arch Pediatr Infect Dis, (In press).
-
- Heidary M, Bahramian A, Goudarzi H, et al. (2016). To study the association between AcrAB and Qep A efflux pumps and ciprofloxacin resistance among Escherichia coli and Klebsiella pneumoniae clinical strains. Arak Med Univ J, 19(4):1–10.
-
- World Health Organization (2014). Antimicrobial resistance: global report on surveillance. http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf?...
-
- Vardakas KZ, Matthaiou DK, Falagas ME, et al. (2015). Characteristics, risk factors and outcomes of carbapenem resistant Klebsiella pneumoniae infections in the intensive care unit. J Infect, 70(6):592–9. - PubMed
Publication types
LinkOut - more resources
Full Text Sources